Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia

by Gregory W. Roloff, Catherine Lai, Christopher S. Hourigan, Laura W. Dillon
Published 2017-09-01

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

by Nestor R. Ramos, Clifton C. Mo, Judith E. Karp, Christopher S. Hourigan
Published 2015-04-01

Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia

by Enkhtsetseg Purev, Bogdan Dumitriu, Christopher S. Hourigan, Neal S. Young, Danielle M. Townsley
Published 2014-01-01

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia

by Meghali Goswami, Katherine E. Lindblad, Rahul Ramraj, Pradeep K. Dagur, Julie Thompson, J. Philip McCoy, Christopher S. Hourigan
Published 2020-07-01

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

by Bogdan Popescu, Sheenu Sheela, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Christopher S. Hourigan, Catherine Lai
Published 2019-12-01

Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation

by Lisa J. McReynolds, Yubo Zhang, Yanqin Yang, Jingrong Tang, Matthew Mulé, Amy P. Hsu, Danielle M. Townsley, Robert R. West, Jun Zhu, Dennis D. Hickstein, Steven M. Holland, Katherine R. Calvo, Christopher S. Hourigan
Published 2019-01-01

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection

by Sheenu Sheela, Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor-Garcia, Hao-Wei Wang, Karolyn A. Oetjen, Kamile A. West, Austin J. Barrett, Mark Parta, Juan Gea-Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai
Published 2017-01-01

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

by Meghali Goswami, Gabrielle Prince, Angelique Biancotto, Susan Moir, Lela Kardava, Brian H. Santich, Foo Cheung, Yuri Kotliarov, Jinguo Chen, Rongye Shi, Huizhi Zhou, Hana Golding, Jody Manischewitz, Lisa King, Lauren M. Kunz, Kimberly Noonan, Ivan M. Borrello, B. Douglas Smith, Christopher S. Hourigan
Published 2017-07-01

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

by Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Published 2019-01-01

Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.

by Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen
Published 2021-01-01